Stratec SE

XTRA:SBS 주식 리포트

시가총액: €207.1m

Stratec 향후 성장

Future 기준 점검 4/6

Stratec (는) 각각 연간 36.6% 및 7.2% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 38.8% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 8.6% 로 예상됩니다.

핵심 정보

36.6%

이익 성장률

38.75%

EPS 성장률

Medical Equipment 이익 성장13.5%
매출 성장률7.2%
향후 자기자본이익률8.61%
애널리스트 커버리지

Good

마지막 업데이트12 May 2026

최근 향후 성장 업데이트

분석 기사 Nov 11

Stratec SE (ETR:SBS) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Stratec SE ( ETR:SBS ) shareholders are probably feeling a little disappointed, since its shares fell 5.2% to €21.75 in...

Recent updates

내러티브 업데이트 May 08

SBS: Lower Growth Assumptions Will Still Allow Future Upside Potential

The analyst fair value estimate for Stratec has been revised from about €26.00 to about €20.00, as analysts trim price targets and factor in lower revenue growth assumptions, softer profit margin expectations, and a higher implied future P/E, in line with recent target cuts from major banks. Analyst Commentary Recent Street research reflects a more cautious stance on Stratec, with price targets revised lower and expectations reset around revenue growth and profitability.
내러티브 업데이트 Apr 21

SBS: Rebased Fair Value And 2025 Margin Guidance Will Define Upside Potential

The analyst price target for Stratec has been cut from about €44.96 to €34.00, as analysts factor in updated fair value, discount rate, growth, margin, and P/E assumptions following recent target revisions from major banks. Analyst Commentary Recent research suggests that while headline price targets for Stratec have come down, some bullish analysts still see potential upside at current levels.
내러티브 업데이트 Apr 06

SBS: Future Upside Will Rely On Reset Margins And Higher P/E

Narrative Update on Stratec The updated analyst price target for Stratec is €28.46, reflecting recent target cuts of up to €12 from prior Street research as analysts factor in a slightly higher discount rate, modestly adjusted profit margin assumptions, and a higher future P/E multiple. Analyst Commentary Recent research commentary on Stratec has focused on recalibrating price targets while keeping an eye on execution risk and the valuation investors are being asked to pay.
내러티브 업데이트 Mar 23

SBS: Future Upside Will Depend On Repriced Earnings Power And Margins

Analysts have trimmed their average price target for Stratec by around €2.40, with recent cuts to €34 helping to explain a slightly lower fair value estimate and modestly softer assumptions for growth, margins and future P/E. Analyst Commentary Recent research revisions on Stratec point to a reset in expectations, with lower price targets feeding into updated views on valuation, execution risk and growth assumptions.
내러티브 업데이트 Mar 09

SBS: Higher Discount Rate And Index Removal Will Still Allow Future Upside

Narrative Update on Stratec The analyst price target for Stratec has been reduced by €1, as analysts reflect slightly adjusted assumptions around discount rates, revenue growth and profit margins in their updated models. Analyst Commentary Bearish analysts trimming their price targets, including the recent €1 reduction, are signaling a more cautious stance on Stratec.
내러티브 업데이트 Feb 22

SBS: Higher Discount Rate Will Still Allow Future Upside Potential

Analysts have reduced their price target on Stratec by €1 to €26, reflecting updated assumptions regarding the company’s discount rate, revenue growth, profit margin and future P/E profile. Analyst Commentary Bearish analysts cutting the price target to €26 are signaling a more cautious stance on Stratec’s risk and reward trade off at current levels.
내러티브 업데이트 Feb 08

SBS: Future Upside Will Rely On Earnings Power And Cost Controls

Narrative update on Stratec Analysts have trimmed their 12 month price target on Stratec by about €1, reflecting updated assumptions around fair value, discount rate, revenue growth, profit margin and future P/E. Analyst Commentary Recent research updates on Stratec point to a small pullback in published price targets, with a reduction of about €1 in the latest move and a prior cut from €30 to €27.
내러티브 업데이트 Jan 23

SBS: Future Margin Recovery Will Rely On Efficiency Gains And Cost Controls

Analysts have trimmed their price target on Stratec, with the average moving slightly lower in line with a recent cut from €30 to €27, citing updated assumptions around fair value, discount rate, revenue growth, profit margin and future P/E. Analyst Commentary Recent research points to a more cautious stance on Stratec, with the reduced €27 price target reflecting updated views on what analysts see as fair value, the applied discount rate, revenue growth assumptions, margin profile and future P/E expectations.
분석 기사 Jan 10

Returns On Capital Signal Tricky Times Ahead For Stratec (ETR:SBS)

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...
내러티브 업데이트 Jan 08

SBS: Index Exit And 2025 Margin Guidance Will Define Upside Potential

Analysts have trimmed their fair value estimate for Stratec from about €51.00 to roughly €44.96. This aligns with a recent reduction in the Street price target to €27 from €30 as they factor in updated assumptions on discount rates, revenue growth, profit margins, and future P/E multiples.
내러티브 업데이트 Dec 18

SBS: Margin Recovery Outlook Will Support Upside Despite Reduced Price Objective

Analysts have trimmed their price target on Stratec to EUR 27.00 from EUR 30.00, reflecting slightly more cautious assumptions on long term growth, a higher discount rate, and a modestly lower future P E multiple, despite marginally improved margin expectations. Analyst Commentary Bearish analysts have highlighted that the reduction in the price target to EUR 27.00 signals a more guarded stance on Stratec's medium to long term prospects, even as the rating on the shares remains unchanged at Hold.
내러티브 업데이트 Dec 04

SBS: Future Margin Gains Will Emerge As Cost Controls Take Hold

Analysts have modestly reduced their price target on Stratec, trimming it by EUR 3 to EUR 27. This reflects slightly lower long term return expectations while maintaining a cautious stance on the shares.
분석 기사 Nov 29

Stratec (ETR:SBS) Takes On Some Risk With Its Use Of Debt

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
내러티브 업데이트 Nov 20

SBS: Margins Will Improve With Cost Management And Leadership Changes

The analyst price target for Stratec has been revised downward from €30 to €27. Analysts cited a slightly higher discount rate and modest changes in growth and profitability expectations as key drivers behind the adjustment.
분석 기사 Nov 11

Stratec SE (ETR:SBS) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Stratec SE ( ETR:SBS ) shareholders are probably feeling a little disappointed, since its shares fell 5.2% to €21.75 in...
분석 기사 Nov 07

Investors Give Stratec SE (ETR:SBS) Shares A 35% Hiding

Stratec SE ( ETR:SBS ) shares have had a horrible month, losing 35% after a relatively good period beforehand. The drop...
내러티브 업데이트 Nov 03

SBS: Future Leadership Will Drive Healthcare Diagnostics Forward Amidst Margin Pressures

Analysts have revised their price target for Stratec downward from €36.58 to €33.30, citing expectations of slower revenue growth and a slight decrease in profit margins. What's in the News Tanja Bücherl will join STRATEC SE's Board of Management as Chief Financial Officer effective November 1, 2025.
분석 기사 Sep 23

Getting In Cheap On Stratec SE (ETR:SBS) Might Be Difficult

Stratec SE's ( ETR:SBS ) price-to-earnings (or "P/E") ratio of 25.3x might make it look like a sell right now compared...
내러티브 업데이트 Aug 23

Automation And Digitalization Will Transform Healthcare Diagnostics

Stratec’s consensus price target has been revised downward, primarily reflecting lowered forecasts for both revenue growth and net profit margin, resulting in a new fair value of €37.32. What's in the News Stratec increased its dividend to €0.60 per share for 2024 (previously €0.55), totaling €7.3 million to be distributed.
분석 기사 Jun 17

An Intrinsic Calculation For Stratec SE (ETR:SBS) Suggests It's 34% Undervalued

Key Insights Stratec's estimated fair value is €36.05 based on 2 Stage Free Cash Flow to Equity Stratec is estimated to...
분석 기사 Apr 25

Why We're Not Concerned About Stratec SE's (ETR:SBS) Share Price

With a price-to-earnings (or "P/E") ratio of 30.8x Stratec SE ( ETR:SBS ) may be sending very bearish signals at the...
User avatar
새로운 내러티브 Feb 09

Efficiency Measures And Acquisitions Like Natech Will Boost Future Market Presence

Efficiency measures and cost discipline initiatives could enhance net margins as market conditions stabilize.
분석 기사 Jan 18

An Intrinsic Calculation For Stratec SE (ETR:SBS) Suggests It's 42% Undervalued

Key Insights Using the 2 Stage Free Cash Flow to Equity, Stratec fair value estimate is €55.10 Stratec's €32.10 share...
분석 기사 Nov 09

With A 25% Price Drop For Stratec SE (ETR:SBS) You'll Still Get What You Pay For

Stratec SE ( ETR:SBS ) shares have had a horrible month, losing 25% after a relatively good period beforehand. The drop...
분석 기사 Oct 26

Returns At Stratec (ETR:SBS) Appear To Be Weighed Down

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Amongst other things...
분석 기사 May 11

Here's Why It's Unlikely That Stratec SE's (ETR:SBS) CEO Will See A Pay Rise This Year

Key Insights Stratec to hold its Annual General Meeting on 17th of May Total pay for CEO Marcus Wolfinger includes...
분석 기사 Apr 11

Stratec's (ETR:SBS) Dividend Will Be Reduced To €0.55

Stratec SE's ( ETR:SBS ) dividend is being reduced from last year's payment covering the same period to €0.55 on the...
분석 기사 Apr 01

Stratec SE Just Missed EPS By 24%: Here's What Analysts Think Will Happen Next

Shareholders might have noticed that Stratec SE ( ETR:SBS ) filed its yearly result this time last week. The early...
분석 기사 Mar 28

Stratec (ETR:SBS) Has Announced That Its Dividend Will Be Reduced To €0.55

The board of Stratec SE ( ETR:SBS ) has announced it will be reducing its dividend by 43% from last year's payment of...
분석 기사 Dec 21

Is There An Opportunity With Stratec SE's (ETR:SBS) 36% Undervaluation?

Key Insights Stratec's estimated fair value is €67.40 based on 2 Stage Free Cash Flow to Equity Stratec's €43.00 share...
분석 기사 Nov 03

Slowing Rates Of Return At Stratec (ETR:SBS) Leave Little Room For Excitement

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
분석 기사 Oct 19

We Think Stratec (ETR:SBS) Is Taking Some Risk With Its Debt

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
분석 기사 Jul 12

Return Trends At Stratec (ETR:SBS) Aren't Appealing

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...
분석 기사 Jun 27

Stratec SE (ETR:SBS) Shares Could Be 43% Below Their Intrinsic Value Estimate

Key Insights Stratec's estimated fair value is €110 based on 2 Stage Free Cash Flow to Equity Stratec is estimated to...
분석 기사 May 25

Is Stratec (ETR:SBS) Using Too Much Debt?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

이익 및 매출 성장 예측

XTRA:SBS - 애널리스트 향후 추정치 및 과거 재무 데이터 (EUR Millions)
날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수
12/31/20282972016314
12/31/20272861818316
12/31/20262681424316
3/31/2026244-31024N/A
12/31/20252510-170N/A
9/30/202526015322N/A
6/30/202526415726N/A
3/31/2025266172543N/A
12/31/2024258163149N/A
9/30/2024256131834N/A
6/30/2024258171633N/A
3/31/202425212-116N/A
12/31/202327015219N/A
9/30/202325512-22-1N/A
6/30/202326219-31-11N/A
3/31/202326019-515N/A
12/31/202227529-910N/A
9/30/2022270281835N/A
6/30/2022269273755N/A
3/31/2022291403050N/A
12/31/2021287404363N/A
9/30/2021296464063N/A
6/30/2021286412953N/A
3/31/2021266352043N/A
12/31/202025028632N/A
9/30/202023524529N/A
6/30/202022521-420N/A
3/31/202022417-1215N/A
12/31/201921414N/A21N/A
9/30/201921214N/A8N/A
6/30/201920714N/A13N/A
3/31/201919511N/A9N/A
12/31/201818811N/A12N/A
9/30/201819316N/A20N/A
6/30/201819723N/A28N/A
3/31/201819824N/A28N/A
12/31/201720727N/A30N/A
9/30/201720828N/A30N/A
6/30/201720620N/A21N/A
3/31/201720319N/AN/AN/A
12/31/201618519N/A16N/A
9/30/201616614N/A17N/A
6/30/201615519N/A23N/A
3/31/201614421N/AN/AN/A
12/31/201514722N/A26N/A
9/30/201514722N/A35N/A
6/30/201514621N/A35N/A

애널리스트 향후 성장 전망

수입 대 저축률: SBS 은 향후 3년 동안 수익을 낼 것으로 예상되며, 이는 절약률(1.9%)보다 빠른 성장으로 간주됩니다.

수익 vs 시장: SBS (는) 향후 3년 동안 평균 시장 성장보다 높은 수익을 올릴 것으로 예상됩니다.

고성장 수익: SBS 향후 3년 내에 수익을 낼 것으로 예상됩니다.

수익 대 시장: SBS 의 수익(연간 7.2%)이 German 시장(연간 6.8%)보다 빠르게 성장할 것으로 예상됩니다.

고성장 매출: SBS 의 수익(연간 7.2%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.


주당순이익 성장 예측


향후 자기자본이익률

미래 ROE: SBS의 자본 수익률은 3년 후 8.6%로 낮을 것으로 예상됩니다.


성장 기업 찾아보기

기업 분석 및 재무 데이터 상태

데이터최종 업데이트 (UTC 시간)
기업 분석2026/05/21 13:40
종가2026/05/21 00:00
수익2026/03/31
연간 수익2025/12/31

데이터 소스

당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.

패키지데이터기간미국 소스 예시 *
기업 재무제표10년
  • 손익계산서
  • 현금흐름표
  • 대차대조표
분석가 컨센서스 추정치+3년
  • 재무 예측
  • 분석가 목표주가
시장 가격30년
  • 주가
  • 배당, 분할 및 기타 조치
지분 구조10년
  • 주요 주주
  • 내부자 거래
경영진10년
  • 리더십 팀
  • 이사회
주요 개발10년
  • 회사 공시

* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.

별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 스노우플레이크

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드YouTube 튜토리얼도 제공합니다.

Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.

산업 및 섹터 지표

산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.

분석가 소스

Stratec SE는 11명의 분석가가 다루고 있습니다. 이 중 6명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.

분석가기관
Michael HeiderBerenberg
Jan KochDeutsche Bank
Jan KochDeutsche Bank